Pharmaron Beijing (HKG:3759, SHE:300759) bought back a total of 9,608,288 A shares between May 8 and July 25 for nearly 200.1 million yuan, a July 26 filing said.
The shares represent roughly 0.54% of the Chinese drug developer's total issued share capital.
The shares were bought for the highest and lowest price of 22.27 yuan and 17.89 yuan apiece, respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments